Anti-IgSF4 antibody and utilization of the same

It is intended to clarify a molecule which is available as a target in treating or diagnosing cancer and utilize the molecule in the medical field or the research field. By treating IgSF4, which has been identified as a molecule specifically expressen in lung cancer cells, with an antibody, and ADCC...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: KAZUHIRO MORISHITA, CHIHO MURAMATSU, KAZUHIRO SUZUKI, MARIKO SUMITOMO, KAZUKI MATSUDA, YASUSHI AKAHORI, NOBUHIRO TAKAHASHI, MIWA MORITA, YOSHINORI UKAI, SARI FUJIYAMA, SUSUMU TSUTSUMI, NOBUHIRO HAYASHI, KEIKO OGAWA, ATSUSHI SUGIOKA, YOSHITAKA IBA, MASACHIKA AZUMA, AKIHIKO TAKASAKI, GENE KUROSAWA, YOSHIKAZU KUROSAWA
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:It is intended to clarify a molecule which is available as a target in treating or diagnosing cancer and utilize the molecule in the medical field or the research field. By treating IgSF4, which has been identified as a molecule specifically expressen in lung cancer cells, with an antibody, and ADCC activity is exerted. Based on this finding, an anti-IgSF4 antibody is provided as a means efficacious in treatig cancer, etc.